Common Contracts

SEVENTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

Investor Rights Agreement • June 2nd, 2017 • Aileron Therapeutics Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Investor Rights Agreement
• Filed
  June 2nd, 2017
• Company
  Aileron Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

SEVENTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, dated as of December 23, 2016 (this “Agreement”), among AILERON THERAPEUTICS, INC., a Delaware corporation (the “Issuer”), and the investors in the Issuer named in Schedule I hereto (collectively, the “Investors”), amending and restating the Sixth Amended and Restated Investor Rights Agreement, dated as of October 14, 2014 (the “Sixth Amended and Restated Investor Rights Agreement”), among the Issuer and the Investors.

SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

Investor Rights Agreement • September 10th, 2015 • Aileron Therapeutics Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Investor Rights Agreement
• Filed
  September 10th, 2015
• Company
  Aileron Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, dated as of October 14, 2014 (this “Agreement”), among AILERON THERAPEUTICS, INC., a Delaware corporation (the “Issuer”), and the investors in the Issuer named in Schedule I hereto (collectively, the “Investors”), amending and restating the Fifth Amended and Restated Investor Rights Agreement, dated as of November 5, 2013 (the “Fifth Amended and Restated Investor Rights Agreement”), among the Issuer and the Investors.

FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

Investor Rights Agreement • May 2nd, 2014 • Tokai Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Investor Rights Agreement
• Filed
  May 2nd, 2014
• Company
  Tokai Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, dated as of May 13, 2013 (this “Agreement”), among TOKAI PHARMACEUTICALS, INC., a Delaware corporation (the “Issuer”), and the investors in the Issuer named in Schedule I hereto (collectively, the “Investors”), amending and restating the Fourth Amended and Restated Investor Rights Agreement, dated as of September 9, 2011, as amended (the “Fourth Amended and Restated Investor Rights Agreement”), among the Issuer and certain of the Investors.